Notification That Annual Report Will Be Submitted Late (nt 10-k)
April 01 2022 - 06:06AM
Edgar (US Regulatory)
|
UNITED STATES |
|
|
SECURITIES AND EXCHANGE COMMISSION |
SEC
File No: 000-55572 |
|
Washington, D.C. 20549 |
CUSIP No: 42227D100 |
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ]
Form 10-Q [ ] Form 10-D [ ] Form N-SAR
[ ]
Form N-CSR
For
Period Ended December 31, 2021
¨ |
|
Transition report on Form
10-K |
¨ |
|
Transition report on Form 20-F |
¨ |
|
Transition report on Form 11-K |
¨ |
|
Transition report on Form 10-Q |
¨ |
|
Transition report on Form N-SAR |
For
the Transition Period Ended: ______________
Read Instruction (on back page)
Before Preparing Form. Please Print or Type. |
Nothing in this form shall be
construed to imply that the Commission has verified any information
contained herein. |
If
the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
__________________________________________________________________________
PART 1 -- REGISTRANT
INFORMATION |
|
HEALTHY EXTRACTS INC. |
Full Name of Registrant |
|
Former Name if Applicable |
|
6445 SOUTH TENAYA WAY, SUITE
B110 |
Address of Principal Executive Office (Street
and Number) |
|
LAS VEGAS, NV 89113 |
City, State and Zip Code |
PART II -- RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if
appropriate)
|
(a) |
The reason described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense; |
|
|
|
☒ |
(b) |
The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, Form 11- K, Form N-SAR or Form N-CSR,
or portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the subject
quarterly report or transition report or transition report on Form 10-Q or subject
distribution report on Form 10-D, or portion thereof, will be filed
on or before the fifth calendar day following the prescribed due
date; and |
|
|
|
|
(c) |
The accountant’s statement or other exhibit required by Rule
12b-25(c) has been attached if applicable. |
PART III -- NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F,
11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion
thereof, could not be filed within the prescribed time period.
The Registrant was unable to
complete the preparation of it's Form 10-K document for the period
ended December 31, 2021 in a timely matter because of unanticipated
delays.
PART IV-- OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this
notification
KEVIN PITTS |
702 |
463-1004 |
(Name) |
(Area Code) |
(Telephone Number) |
(2) Have all other periodic reports required under Section 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or
for such shorter period that the registrant was required to file
such report(s) been filed? If answer is no, identify report(s).
[ X
]Yes [ ] No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the
subject report or portion thereof?
[ ]Yes [ X ] No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be
made.
HEALTHY EXTRACTS
INC. |
(Name of Registrant as Specified in
Charter) |
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date |
MARCH 31, 2022 |
By: |
/s/ KEVIN PITTS |
|
|
Title: |
PRESIDENT |
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name
and title of the person signing the form shall be typed or printed
beneath the signature. If the statement is signed on behalf of the
registrant by an authorized representative (other than an executive
officer), evidence of the representative's authority to sign on
behalf of the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or
omissions of fact constitute Federal Criminal Violations (See 18
U.S.C. 1001) |
Healthy Extracts (QB) (USOTC:HYEX)
Historical Stock Chart
From May 2023 to Jun 2023
Healthy Extracts (QB) (USOTC:HYEX)
Historical Stock Chart
From Jun 2022 to Jun 2023